Clinical Trial

Safety and Efficacy of Adaptive Deep Brain Stimulation

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 9, 2024 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to assess the safety and the potential efficacy of personalized Local Field Potential (LFP)-based adaptive Deep Brain Stimulation (aDBS), using the implantable pulse generator (IPG) of the "AlphaDBS" System, in Parkinson's Disease patients, chronically implanted in subthalamic nucleus (STN) for DBS.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT04681534
Lead Sponsor Newronika
Conditions Parkinson Disease
Enrollment 15 participants
Start Date 2021-01-26
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-09